Rheumatoid arthritis

Serum antibodies to periodontal pathogens prior to rheumatoid arthritis diagnosis: A case-control study

Semin Arthritis RheumPublished Case-control study

Authors' conclusion

No longitudinal elevations of anti-bacterial serum antibody concentrations were observed in RA patients prior to RA diagnosis compared to controls.

Study context

Population
Serum samples from the U.S. Department of Defense Serum Repository, pre- and post-RA diagnosis
Participants
214 vs 210
Comparison
Rheumatoid arthritis (RA) cases vs matched controls
  • RA casesn = 214
  • Controlsn = 210reference
Outcome
Association between anti-Porphyromonas gingivalis serum antibody concentrations and the risk of developing RA (timing of antibody elevations relative to RA diagnosis, cases vs controls)
Methodological detailsmatched controls, longitudinal pre- and post-diagnosis serum samples, mixed-effects linear regression models
  • Matched controls
  • Longitudinal pre- and post-diagnosis serum samples
  • Mixed-effects linear regression models

Main finding

As reported in the abstract

Serum anti-P. gingivalis, anti-F. nucleatum and anti-P. intermedia concentrations before RA diagnosis
  • No compelling evidence of case-control divergence in serum anti-P. gingivalis, anti-F. nucleatum, and anti-P. intermedia

Observational data: associations, not effects.

Further findings

Association of anti-P. intermedia with RA autoantibodies among RA cases (all pre-diagnosis samples)

anti-P. intermedia significantly positively associated with anti-CCP2, ACPA fine specificities (vimentin, histone, alpha-enolase) and IgA RF
P < 0.001
anti-P. intermedia significantly positively associated with IgG RF
P = 0.049
anti-P. intermedia significantly positively associated with IgM RF
P = 0.004
anti-P. gingivalis and anti-F. nucleatum not associated with RA autoantibodies

Original publication

Serum antibodies to periodontal pathogens prior to rheumatoid arthritis diagnosis: A case-control study. Semin Arthritis Rheum. Published 11 February 2023. doi:10.1016/j.semarthrit.2023.152176

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.